Search results for "RESPIRATORY SYSTEM"

showing 10 items of 1829 documents

Severe eosinophilic asthma: a roadmap to consensus

2017

Asthma is widely accepted as a complex heterogeneous condition with diverse pathophysiological mechanisms, clinical presentations, comorbidities, physiological characteristics, pathology and outcomes that is typically best managed by a multidisciplinary team [1–4]. Severe asthma is recognised as a major unmet need with a high personal and social impact, as well as a high burden on healthcare resources [4]. As a consequence of advances in the development of precision medicines for patients with severe asthma, the need to identify asthma subtypes by phenotype based on clinical, functional or inflammatory parameters is becoming a mandatory part of management [4–6]. Severe eosinophilic asthma (…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusEosinophilic asthmamacromolecular substancesSeverity of Illness IndexBiological Factors03 medical and health sciences0302 clinical medicineimmune system diseasesEosinophilicmedicineHumans030212 general & internal medicinePulmonary EosinophiliaIntensive care medicineSocieties MedicalTask forcebusiness.industryDisease ManagementAsthmarespiratory tract diseasesEurope030228 respiratory systemImmunologybusinessEuropean Respiratory Journal
researchProduct

A review of venous thromboembolism in COVID‐19: A clinical perspective

2021

Abstract Coronavirus disease‐19 (COVID‐19) started in Wuhan, China in December 2019 and spread to all around the world in a short period of time. Hospitalized patients with COVID‐19 mostly could suffer from an abnormal coagulation activation risk with increased venous thrombosis events and a poor clinical course. The reported incidence rates of thrombotic complications in hospitalized COVID‐19 patients vary between 2.6 and 85% (both in non‐critically ill and critically ill patients). The risk of venous thromboembolism is not known in non‐hospitalized patients with COVID‐19. There are numerous studies and guidelines for administration of thromboprophylaxis for COVID‐19 cases. All hospitalize…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Hospitalized patientsCritical IllnessGlobal Health03 medical and health sciences0302 clinical medicineCOVID‐19medicineHumansImmunology and AllergyGenetics(clinical)030212 general & internal medicineanticoagulationIntensive care medicinePandemicsContraindicationGenetics (clinical)Critical perspectiveSARS-CoV-2business.industryCritically illIncidenceCOVID-19Venous ThromboembolismOriginal Articlesmedicine.diseasemortalityLMWHVenous thrombosis030228 respiratory systemOriginal Articlevenous thrombosisbusinessVenous thromboembolismThrombotic complicationThe Clinical Respiratory Journal
researchProduct

Acute and sustained increase in endothelial biomarkers in COVID-19.

2020

Endothelial injury is related to poor outcomes in respiratory infections yet little is known in relation to COVID-19. Performing a longitudinal analysis (on emergency department admission and post-hospitalisation follow-up), we evaluated endothelial damage via surrogate systemic endothelial biomarkers, that is, proadrenomedullin (proADM) and proendothelin, in patients with COVID-19. Higher proADM and/or proendothelin levels at baseline were associated with the most severe episodes and intensive care unit admission when compared with ward-admitted individuals and outpatients. Elevated levels of proADM or proendothelin at day 1 were associated with in-hospital mortality. High levels maintaine…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryRespiratory infectionCOVID-19Emergency departmentmedicine.diseaseIntensive care unitlaw.inventionHospitalizationPneumoniaIntensive Care UnitslawDiffusing capacityInternal medicinemedicineCardiologyHumansIn patientHospital MortalityRespiratory systembusinessBiomarkersThorax
researchProduct

The optimal imaging test for diagnosis of acute pulmonary embolism: a second chance for lung scintigraphy?

2020

Ventilation–perfusion scintigraphy may continue to be the first-line diagnostic method for pulmonary embolism in institutions that can ensure its uninterrupted availability and the expertise in its interpretationhttps://bit.ly/2y3Dlhx

Pulmonary and Respiratory Medicinemedicine.medical_specialtyDiagnostic methodsCardiologyScintigraphyVentilation/perfusion ratio03 medical and health sciences0302 clinical medicineVentilation-Perfusion RatiomedicineHumansRadionuclide imaging030212 general & internal medicineRadionuclide ImagingProbabilityLungmedicine.diagnostic_testbusiness.industryfood and beveragesmedicine.diseasePulmonary embolismmedicine.anatomical_structure030228 respiratory systemRadiologyPulmonary EmbolismbusinessEuropean Respiratory Journal
researchProduct

Obstructive sleep apnea and comorbidities: a dangerous liaison

2018

Obstructive sleep apnea (OSA) is a highly prevalent disease, and is traditionally associated with increased cardiovascular risk. The role of comorbidities in OSA patients has emerged recently, and new conditions significantly associated with OSA are increasingly reported. A high comorbidity burden worsens prognosis, but some data suggest that CPAP might be protective especially in patients with comorbidities. Aim of this narrative review is to provide an update on recent studies, with special attention to cardiovascular and cerebrovascular comorbidities, the metabolic syndrome and type 2 diabetes, asthma, COPD and cancer. Better phenotypic characterization of OSA patients, including comorbi…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyDiseaseType 2 diabetesReviewSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciences0302 clinical medicinecardiovascular diseaseDiabetes mellitusmedicinecancerCOPDMortalityIntensive care medicineAsthmalcsh:RC705-779COPDdiabetesbusiness.industrylcsh:Diseases of the respiratory systemasthmamedicine.diseaseComorbiditynervous system diseasesrespiratory tract diseasesObstructive sleep apnea030228 respiratory systemdiabeteprognosisMetabolic syndromebusiness030217 neurology & neurosurgeryMultidisciplinary Respiratory Medicine
researchProduct

Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular Ballooning) in Takotsubo Syndrome

2021

Background The short- and long-term prognosis of Takotsubo syndrome (TTS) presenting with right ventricular (RV) involvement remains poorly understood. Research Question What is the incidence and clinical outcome of RV involvement in TTS? Study Design and Methods This study analyzed 839 consecutive patients with TTS (758 female subjects and 81 male subjects) in a multicenter registry. RV involvement was defined as wall motion abnormality of the RV free wall, with or without apical involvement. The median long-term follow-up was 2.1 years (interquartile range, 0.3-4.5 years). The primary outcome was in-hospital and out-of-hospital all-cause mortality. The secondary end point was a composite …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEjection fractionbusiness.industryCardiogenic shockIncidence (epidemiology)Hazard ratioCritical Care and Intensive Care Medicinemedicine.diseasePulmonary edemaClinical trial03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineCohortmedicineCardiology030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy

2017

Reslizumab, an anti-interleukin-5 monoclonal antibody, significantly reduces exacerbation frequency and improves lung function, asthma control and quality of life in adults with severe eosinophilic asthma, as demonstrated in Phase III studies. This secondary analysis assessed reslizumab's efficacy in patients receiving baseline treatment per Global Initiative for Asthma (GINA) Step 4 and Step 5 guidelines. Pooled data from duplicate, Phase III, reslizumab versus placebo studies in patients with severe eosinophilic asthma (blood eosinophils ≥400 cells·µL−1) were stratified by baseline therapy. Efficacy assessments were exacerbation rates and changes from baseline forced expiratory volume in …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbation2lcsh:MedicineEosinophilic asthmaPlacebo03 medical and health sciences0302 clinical medicineQuality of lifeReslizumabInternal medicineSecondary analysismedicineMedicine and Health Sciences030212 general & internal medicineLung functionAsthmabusiness.industrylcsh:ROriginal Articlesmedicine.diseaseSurgery030228 respiratory systembusinessmedicine.drugERJ Open Research
researchProduct

Response to mepolizumab treatment is sustained across 4-weekly dosing periods

2020

Background Mepolizumab (100 mg delivered s.c. every 4 weeks) is indicated for add-on maintenance treatment for patients with severe eosinophilic asthma. Mepolizumab has been shown to reduce exacerbations and the requirement for daily oral corticosteroids, and improve asthma control and symptoms. However, data on the durability of the response to mepolizumab during dosing periods are limited. The aim of this study was to investigate the efficacy profile in patients with severe eosinophilic asthma over the 4-weekly dosing period for various fixed mepolizumab doses. Methods This was a post hoc analysis of data from the phase IIb/III DREAM study. Patients ≥12 years of age with severe eosinophil…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationbusiness.industrylcsh:R2lcsh:MedicineEosinophilic asthma14Original ArticlesPlaceboAsthmaTreatment period03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicinePost-hoc analysisMedicineIn patient030212 general & internal medicineDosingbusinessMepolizumabmedicine.drugERJ Open Research
researchProduct

The respiratory gas values of the fetal and maternal blood in cartesian nomograms

1966

Respiratory gas values of maternal and fetal blood taken at delivery are represented in two Cartesian nomograms. They are based on data, published by vogel, fischer und thews (1965) and Fischer, Vogel und Thews (1965). The nomograms depict the interdependence of O2 pressure, O2 content, CO2 pressure and CO2 content, established by the O2 and CO2 dissociation curves, as well as by the Bohr effect and the Haldane effect. If two of the values are known, the remaining ones can be read from the nomograms.

Pulmonary and Respiratory Medicinemedicine.medical_specialtyFetusPhysiologyChemistryPartial PressureRespirationBohr effectCarbon DioxideMaternal bloodNomogramDelivery ObstetricEndocrinologyPregnancyHaldane effectInternal medicinemedicineCardiologyHumansFemaleBlood Gas AnalysisRespiratory systemMaternal-Fetal ExchangeRespiration Physiology
researchProduct

Could E-cigarette vaping contribute to heart disease?

2020

E-cigarettes have become a controversial topic. While their benefits are questioned by the scientific community, a part of the medical profession is still supporting them as an effective harm reduction tool for smoking cessation. The impact of E-cigarettes on the cardiovascular system is still elusive.We assessed results from animal, pre(clinical), and epidemiological studies to critically evaluate and synthesize evidence relevant to the cardiovascular effects of E-cigarettes. Animal studies have demonstrated that E-cigarette vapor exposure can cause endothelial and cardiac dysfunction. However, there have also been reports on the less harmful effects of E-cigarette vapor exposure in compar…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyHeart diseaseHeart DiseasesElectronic Nicotine Delivery Systemsmedicine.disease_cause03 medical and health sciences0302 clinical medicinemedicineTobacco SmokingImmunology and AllergyAnimalsHumans030212 general & internal medicineEndothelial dysfunctionIntensive care medicineInhalation Exposurebusiness.industryVapingPublic Health Environmental and Occupational Healthmedicine.diseaseHarm030228 respiratory systemMedical professionSmoking CessationbusinessOxidative stressExpert review of respiratory medicine
researchProduct